Crescent Capital [CCAP] vs Sprott [SII] Detailed Stock Comparison
Crescent Capital
NASDAQ
Loading...
Sprott
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Crescent Capital wins in 8 metrics, Sprott wins in 10 metrics, with 0 ties. Sprott appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Crescent Capital | Sprott | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.75 | 32.24 | Crescent Capital |
| Price-to-Book Ratio | 0.78 | 4.67 | Crescent Capital |
| Debt-to-Equity Ratio | 122.44 | 0.00 | Sprott |
| PEG Ratio | -0.50 | -17.09 | Sprott |
| EV/EBITDA | N/A | 20.89 | N/A |
| Profit Margin (TTM) | 24.12% | 25.21% | Sprott |
| Operating Margin (TTM) | 75.45% | 34.38% | Crescent Capital |
| EBITDA Margin (TTM) | 75.45% | 34.38% | Crescent Capital |
| Return on Equity | 5.98% | 14.34% | Sprott |
| Return on Assets (TTM) | 5.27% | 10.90% | Sprott |
| Free Cash Flow (TTM) | $58.91M | $67.28M | Sprott |
| Dividend Yield | 16.67% | 1.30% | Crescent Capital |
| 1-Year Return | -17.43% | 46.91% | Sprott |
| Price-to-Sales Ratio (TTM) | 3.07 | 8.20 | Crescent Capital |
| Enterprise Value | $1.44B | $1.55B | Sprott |
| EV/Revenue Ratio | 7.86 | 7.86 | Crescent Capital |
| Gross Profit Margin (TTM) | N/A | 40.02% | N/A |
| Revenue per Share (TTM) | $5 | $8 | Sprott |
| Earnings per Share (Diluted) | $1.19 | $1.94 | Sprott |
| Beta (Stock Volatility) | 0.60 | 1.09 | Crescent Capital |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Crescent Capital vs Sprott Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Crescent Capital | 0.07% | 3.84% | 5.20% | -2.88% | -24.20% | -21.08% |
| Sprott | -3.87% | -5.59% | -16.40% | 10.98% | 45.27% | 43.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Crescent Capital | -17.43% | -13.02% | 24.16% | -7.56% | -7.56% | -7.56% |
| Sprott | 46.91% | 71.91% | 47.53% | 265.73% | 70.87% | 52.91% |
Performance & Financial Health Analysis: Crescent Capital vs Sprott
| Metric | CCAP | SII |
|---|---|---|
| Market Information | ||
| Market Cap | $562.22M | $1.62B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 165,120 | 235,280 |
| 90 Day Avg. Volume | 228,990 | 210,057 |
| Last Close | $15.17 | $62.54 |
| 52 Week Range | $13.54 - $20.19 | $38.44 - $77.16 |
| % from 52W High | -24.86% | -18.95% |
| All-Time High | $21.24 (Oct 11, 2021) | $98.20 (May 02, 2011) |
| % from All-Time High | -28.58% | -36.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | 0.36% |
| Quarterly Earnings Growth | -0.26% | 0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | 0.25% |
| Operating Margin (TTM) | 0.75% | 0.34% |
| Return on Equity (TTM) | 0.06% | 0.14% |
| Debt to Equity (MRQ) | 122.44 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $19.55 | $13.39 |
| Cash per Share (MRQ) | $0.26 | $2.92 |
| Operating Cash Flow (TTM) | $65.36M | $83.88M |
| Levered Free Cash Flow (TTM) | $58.51M | $96.66M |
| Dividends | ||
| Last 12-Month Dividend Yield | 16.67% | 1.30% |
| Last 12-Month Dividend | $2.41 | $0.85 |
Valuation & Enterprise Metrics Analysis: Crescent Capital vs Sprott
| Metric | CCAP | SII |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.75 | 32.24 |
| Forward P/E | 7.51 | 24.15 |
| PEG Ratio | -0.50 | -17.09 |
| Price to Sales (TTM) | 3.07 | 8.20 |
| Price to Book (MRQ) | 0.78 | 4.67 |
| Market Capitalization | ||
| Market Capitalization | $562.22M | $1.62B |
| Enterprise Value | $1.44B | $1.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.86 | 7.86 |
| Enterprise to EBITDA | N/A | 20.89 |
| Risk & Other Metrics | ||
| Beta | 0.60 | 1.09 |
| Book Value per Share (MRQ) | $19.55 | $13.39 |
Financial Statements Comparison: Crescent Capital vs Sprott
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CCAP | SII |
|---|---|---|
| Revenue/Sales | $7.13M | $41.68M |
| Cost of Goods Sold | N/A | $22.11M |
| Gross Profit | N/A | $19.57M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | $14.90M |
| EBITDA | N/A | $15.44M |
| Pre-Tax Income | $4.41M | $15.75M |
| Income Tax | $501,000 | $3.80M |
| Net Income (Profit) | $3.90M | $11.96M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CCAP | SII |
|---|---|---|
| Cash & Equivalents | $12.03M | $55.87M |
| Total Current Assets | N/A | $77.52M |
| Total Current Liabilities | N/A | $22.34M |
| Long-Term Debt | $902.95M | N/A |
| Total Shareholders Equity | $727.12M | $326.15M |
| Retained Earnings | $-232.01M | $-63.04M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CCAP | SII |
|---|---|---|
| Operating Cash Flow | $2.00M | $27.29M |
| Capital Expenditures | N/A | $-592,000 |
| Free Cash Flow | $-15.13M | $13.55M |
| Debt Repayment | $-233.04M | $-253,000 |
| Common Stock Repurchase | N/A | $-552,000 |
Short Interest & Institutional Ownership Analysis
| Metric | CCAP | SII |
|---|---|---|
| Shares Short | 121,167 | 564,087 |
| Short Ratio | 0.44 | 2.99 |
| Short % of Float | 0.01% | N/A |
| Average Daily Volume (10 Day) | 165,120 | 235,280 |
| Average Daily Volume (90 Day) | 228,990 | 210,057 |
| Shares Outstanding | 37.06M | 25.81M |
| Float Shares | N/A | 24.02M |
| % Held by Insiders | 0.13% | 0.17% |
| % Held by Institutions | 0.65% | 0.54% |
Dividend Analysis & Yield Comparison: Crescent Capital vs Sprott
| Metric | CCAP | SII |
|---|---|---|
| Last 12-Month Dividend | $2.41 | $0.85 |
| Last 12-Month Dividend Yield | 16.67% | 1.30% |
| 3-Year Avg Annual Dividend | $2.04 | $1.12 |
| 3-Year Avg Dividend Yield | 1.65% | 0.71% |
| 3-Year Total Dividends | $6.12 | $3.35 |
| Ex-Dividend Date | Aug 29, 2025 | Mar 10, 2025 |